Form 8-K - Current report:
SEC Accession No. 0001087294-26-000043
Filing Date
2026-04-24
Accepted
2026-04-24 17:08:24
Documents
11
Period of Report
2026-04-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cpix-20260421.htm   iXBRL 8-K 37138
  Complete submission text file 0001087294-26-000043.txt   153021

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20260421.xsd EX-101.SCH 1894
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20260421_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20260421_pre.xml EX-101.PRE 12611
14 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20260421_htm.xml XML 2827
Mailing Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203
Business Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 621765329 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 26895645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)